Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China 2019-03-01 10:07
Ascletis Appoints Former MSD Global Vice President Dr. Zhengqing Li as Chief Medical Officer and President of R&D Greater China 2019-03-01 08:00
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors 2019-03-01 07:15
MED-EL Study Shows That a Quarter of Adults Have Never Had Their Hearing Checked 2019-03-01 00:45
Ping An Good Doctor Announces Its 2018 Annual Results 2019-02-28 21:44
Trianni, Inc. Announces Issuance of Patent in Japan 2019-02-28 21:00
Envirotainer Opens RAP e2 Station in Shanghai 2019-02-28 16:28
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma 2019-02-28 08:30
INC: Cashews May Have Fewer Calories Than Previously Thought - New Scientific Findings 2019-02-27 21:11
Ping An Good Doctor's Revenue Up by 78.7% Y-o-Y in 2018 2019-02-27 20:44
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards 2019-02-27 12:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
Blackford Analysis Commended by Frost & Sullivan for its Visionary Implementation of Platform-based Approaches in the Medical Imaging Space 2019-02-26 22:00
Cachet Asset Management to Lead the Latest Round of Funding for ProTom International Holding Company 2019-02-26 19:22
Focusing on Advanced Laboratory Instruments and Equipment, Building an All-around Live-action Space -- 2019 InnoLAB Salon Formally Kicked Off 2019-02-26 15:00
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019 2019-02-26 05:16
1 920 921 922 923 924 1599